Level Chart

Basic Info

Eli Lilly & Co (LLY) - Diabetes Revenue is at a current level of 19.67B, up from 14.46B one year ago. This is a change of 35.97% from one year ago.

Diabetes Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to diabetes within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 19.67B
Latest Period 2023
Last Updated Feb 15 2024, 08:41 EST
Next Release Feb 15 2025, 08:30 EST (E)
Average Growth Rate 14.13%
Value from 1 Year Ago 14.46B
Change from 1 Year Ago 35.97%
Frequency Yearly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2023 19.67B
December 31, 2022 14.46B
December 31, 2021 13.19B
December 31, 2020 11.83B
December 31, 2019 11.13B
December 31, 2018 9.820B
Date Value
December 31, 2017 10.09B
December 31, 2016 8.083B
December 31, 2015 0.00
December 31, 2014 0.00
December 31, 2013 0.00
December 31, 2012 0.00

Basic Info

Eli Lilly & Co (LLY) - Diabetes Revenue is at a current level of 19.67B, up from 14.46B one year ago. This is a change of 35.97% from one year ago.

Diabetes Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to diabetes within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 19.67B
Latest Period 2023
Last Updated Feb 15 2024, 08:41 EST
Next Release Feb 15 2025, 08:30 EST (E)
Average Growth Rate 14.13%
Value from 1 Year Ago 14.46B
Change from 1 Year Ago 35.97%
Frequency Yearly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
LLY Eli Lilly and Co -0.46%